Image

Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability

This study investigates Circulating Tumor DNA as a Surgical Marker in Pancreatic Adenocarcinoma

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic adenocarcinoma. It focuses on the use of circulating tumor DNA (ctDNA) as a marker to determine if surgery is beneficial for patients with this condition.

The study evaluates the prognostic value of ctDNA. This study investigates if ctDNA can predict how well patients respond to treatment and if it can guide decisions on surgical resectability.

  • Who can participate: Adults aged 18 and older with pancreatic adenocarcinoma who are candidates for surgery can participate. Participants must also have a non-metastatic status confirmed by a CT scan and be able to provide informed consent.
  • Study details: Participants will undergo blood tests to measure ctDNA levels. These tests will determine the usefulness of ctDNA as a marker for surgical decisions.
Print
Study details
    PDAC - Pancreatic Ductal Adenocarcinoma

NCT05853198

Azienda Ospedaliera Universitaria Integrata Verona

8 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.